Stent systems coated with antiproliferative medications to reduce restenosis rates. Available for coronary and peripheral vessel applications.
Manufactured by
VascuPatent Medical (Shenzhen) Co., Ltd
China
VascuPatent Medical (Shenzhen) Co., Ltd., established in 2019, is an innovative medical technology company specializing in endovascular intervention devices and components. The company develops products for intracranial, cardiac, and peripheral vascular conditions including thrombosis, stenosis, chronic total occlusion, structural heart disease, and tumor embolization. VascuPatent also offers OEM/ODM services for active and passive medical devices with international quality system standards.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
NVENTRIC
South Korea · 1 relevant product
Freudenberg Medical Hemoteq GmbH
Germany · 7 relevant products
Sino Medical Sciences Technology Inc.
China · 7 relevant products
57 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 109 closest product alternatives
NVENTRIC · South Korea
Coronary stents with pharmaceutical coating designed to prevent restenosis and promote vessel patency. These devices are used for treatment of coronary artery disease.
Freudenberg Medical Hemoteq GmbH · Germany
Specialized stents with controlled drug delivery coatings for sustained release of active pharmaceutical ingredients. Designed to prevent restenosis and maintain vessel patency with optimized clinical performance.
Sino Medical Sciences Technology Inc. · China
Drug-eluting coronary stent system featuring biodegradable polymer coating and optimized elution kinetics for rapid vascular healing. Indicated for percutaneous coronary intervention to restore blood flow in stenosed coronary arteries. The healing-targeted design reduces neointimal proliferation while promoting natural vessel wall healing.
106 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products